Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Luxembourg

Research and Innovation Action · Running

PATH Patient AI Treatment Hub

Coordinator
European Dynamics Luxembourg SA, Luxembourg
Runs
1 February 2026 to 31 July 2029
Status
Running
EU funding
€8.9m
Total cost
€13.3m
Partners
24 organisations in 10 countries
Type
Research and Innovation Action
Grant agreement
101253520

What the project is doing

In the project's own words, from its summary on CORDIS.

Cancer is one of Europe’s leading health burdens, responsible for 26% of all deaths in 2021, with mortality expected to rise by 24% by 2035 and an economic impact exceeding €100 billion annually. Despite the ambitions of Europe’s Beating Cancer Plan, integrating complex cancer data across systems remains a major obstacle. The European Health Data Space (EHDS) seeks to address these gaps, though challenges around interoperability, privacy, and infrastructure persist.

In this context, PATH will transform cancer care by leveraging secure data exchange and digital technologies to improve early detection, diagnosis, treatment, and long-term patient outcomes. Through the integration of AI tools into clinical workflows, PATH will foster a safe, ethical, and sustainable healthcare ecosystem aligned with the Beating Cancer Plan and the EHDS. The project will create a federated, privacy-preserving health data space supporting interoperability and data fairness.

AI models will be trained on representative, FAIR-compliant datasets with built-in transparency and bias mitigation. Federated learning and Trusted Execution Environments will enable secure, real-world model refinement while preserving patient privacy. An AI-powered dashboard will connect clinicians, patients, and developers to deploy validated tools and ensure broad adoption. To ensure long-term impact, PATH will conduct EU-wide pilot studies evaluating clinical outcomes, survivability, efficiency, and cost-effectiveness.

It will also establish scalable business models, promote digital literacy among healthcare professionals, and drive cross-sector collaboration for responsible, evidence-based AI integration across Europe’s cancer care continuum. Delivering this level of clinical, technological, and systemic transformation requires close and sustained collaboration across the entire cancer care and innovation ecosystem. By bringing together the complementary missions, expertise, and capacities of public actors and private companies, the PATH Public–Private Partnership (PPP) composed of 24 partners provides the structural foundation needed to align research excellence, clinical practice, industrial innovation, and policy objectives.

The PPP ensures that PATH solutions are simultaneously scientifically robust, clinically relevant, technologically advanced, and economically sustainable. Moreover, this collaborative framework enhances trust, accelerates knowledge transfer, and supports the translation of innovation from research to real-world healthcare environments—thereby enabling PATH to achieve measurable, scalable, and lasting impact across Europe.

Topics

Who is involved

OrganisationCityCountryRole
European Dynamics Luxembourg SALuxembourgLuxembourgCoordinator
Ainigma TechnologiesLeuvenBelgiumParticipant
HictGentBelgiumParticipant
TimelexBruxelles / BrusselBelgiumParticipant
Linac-Pet Scan Opco LimitedLimassolCyprusParticipant
Pagkyprios Syndesmos Karkinopathon Kai Filon 1986NicosiaCyprusParticipant
Technologiko Panepistimio KyprouLemesosCyprusParticipant
Aristotelio Panepistimio ThessalonikisThessalonikiGreeceParticipant
Ethniko Kai Kapodistriako Panepistimio AthinonAthinaGreeceParticipant
Ethniko Kentro Erevnas Kai Technologikis AnaptyxisThermi ThessalonikiGreeceParticipant
European Dynamics Advanced Information Technology and Telecommunication Systems SAMarousi AthinaGreeceThird party
Geniko Nosokomeio PapageorgiouThessalonikiGreeceParticipant
Idryma Technologias Kai ErevnasIrakleioGreeceParticipant
Panepistimiako Geniko Nosokomeio IrakleiouIrakleioGreeceParticipant
Agora Labs S.r.l.Collevecchio (Ri)ItalyParticipant
Centro Regionale Information E Communication Technology ScrlBeneventoItalyParticipant
Ancora Health BVGroningenNetherlandsParticipant
Fwdfaster Ai Research BVUtrechtNetherlandsParticipant
Universiteit MaastrichtMaastrichtNetherlandsParticipant
Shine 2europe LdaCoimbraPortugalParticipant
University of Novi Sad, Faculty of Medicine Novi SadNovi SadSerbiaParticipant
Univerzitet U Novom Sadu Fakultet Tehnickih NaukaNovi SadSerbiaParticipant
Region SormlandNykopingSwedenParticipant
Wellics LtdLondonUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI